Startup Funding Trends 2026: Where the Money Went in October
A $500M AI agent round, a quantum Series B at a $5.4B valuation, and a biotech winner at Disrupt. This week's startup funding news tells a clear story about 2026 funding trends and what investors want right now.
Quick answer: In the second week of October 2026, AI agent company Manus raised more than $500 million, quantum startup Oratomic raised $475 million at a roughly $5.4 billion valuation, SignSplit emerged from stealth with a $400 million seed, and Intero Biosystems won TechCrunch Disrupt 2026. The pattern: investors are writing their biggest checks for AI infrastructure, proven commercial scale, and startups that pair technology with real operational control, while punishing hype without revenue (see: the Character.AI bankruptcy).
Key numbers at a glance
- $500 million is what AI agent company Manus raised, announced October 8, 2026.
- $475 million is Oratomic's Series B at a roughly $5.4 billion valuation, tripling in one quarter.
- $400 million seed commitment took SignSplit to a $1 billion valuation on day one, paying humans for AI data.
- 85% of the $2.167 billion raised by six US startups on October 16 went to one company, Ramp.
- 199 finalists lost to Intero Biosystems at TechCrunch Disrupt, October 13-15 in San Francisco.
- $2.167 billion in one day is what six US startups raised on October 16, 2026, with Ramp alone accounting for roughly 85% of it.
- $20 million asset sale is how Character.AI ended, selling some assets to Disney after raising at a multi-billion-dollar valuation.
- 775 million dollars total funding for Oratomic since its March 2026 launch, after a 475 million dollar Series B at a roughly 5.4 billion dollar valuation just three months after its Series A.
- More than 10,000 attendees at TechCrunch Disrupt 2026, with twenty finalists competing for the 100,000 dollar Startup Battlefield Cup, won by Intero Biosystems over 199 other startups.
Last reviewed: October 2026.
You will not raise $500 million this month. Almost nobody does. But the deals getting done right now are a weather report for the whole startup climate, and the weather changed this week. An AI agent company survived a reversed acquisition and came back with half a billion dollars. A quantum computing startup tripled its valuation in a single quarter. A biotech company growing miniature human intestines in a lab beat 199 other startups to win TechCrunch Disrupt. And on the same days, one of the most famous AI startups of the last three years filed for bankruptcy.
That mix, euphoria and warning signs in the same week, is exactly why founders should pay attention. Funding news is not gossip. It is a map of where investors believe value will be created next, drawn in dollars. This article reads that map for the second week of October 2026: the headline deals with real numbers, the three patterns underneath them, the cautionary tale, and what all of it means for a founder building something much smaller.
Which startups raised the week's biggest rounds?
Start with the deals themselves, because the numbers set the tone for everything else.
A mega-round is a funding round of $100 million or more. This week's mega-rounds all went to companies with real revenue and real customers behind them, not to demo-stage promise.
Manus raises more than $500 million. The AI agent company Manus closed a round of more than half a billion dollars, announced October 8, its first funding since Meta Platforms was forced to reverse its acquisition of the business. The round was led by private equity firm Boyu Capital and IDG Capital, with follow-on investment from existing shareholders Tencent, HSG, and ZhenFund. The round type was not publicly disclosed. Manus builds general-purpose AI agents that execute multi-step tasks on behalf of users. Step back and consider what this means: few startups survive a reversed acquisition with momentum intact. Manus did, and its new backers are rooted in China, which tells you the future of cross-border AI deals is being redrawn by geopolitics as much as by product. For more on what AI agents actually do for small companies today, see our AI agents for small business playbook.
Oratomic raises $475 million at a $5.4 billion valuation. The Pasadena-based quantum computing company raised $475 million in a round reported as a Series B, lifting its valuation to roughly $5.4 billion, just three months after its Series A. The financing was led by ARCH Venture Partners, Spark Capital, Khosla Ventures, Index Ventures, General Catalyst, and Bezos Expeditions, bringing total funding to $775 million since the company's March 2026 launch. Oratomic was co-founded by quantum heavyweights including John Preskill and Manuel Endres, and it develops neutral-atom hardware plus error-correction architectures aimed at utility-scale quantum machines. A valuation tripling in one quarter is investors saying they now believe fault tolerance is an engineering roadmap, not a physics hope.
SignSplit emerges with a $400 million seed. The New York company came out of stealth with a $400 million strategic seed commitment from W Group, at a $1 billion valuation. Its business: paying humans for AI data. That is worth pausing on. The AI economy now has a big enough appetite for human-labeled data that a seed-stage company in the space can command a unicorn valuation on day one. If you have ever wondered whether data labeling is real work, the market just answered. Our guide to real ways to earn money online covers the smaller-scale version of this same opportunity.
Intero Biosystems wins Disrupt 2026. At TechCrunch Disrupt 2026, held October 13 to 15 at Moscone West in San Francisco with more than 10,000 attendees, twenty finalists competed for the Startup Battlefield Cup and $100,000. The winner: Intero Biosystems, a Denver startup founded by Charlie Childs and Madeline Eiken that spun out of the University of Michigan. The company develops 1mm human intestinal organoids, lab-grown tissue that mimics the gut, giving drug, food, and chemical companies a new way to test compounds before human trials. Its flagship product, GastroScreen, is already selling to pharmaceutical, biotech, food, and chemical companies. The other finalists were Apate, Flox Intelligence, Industrial Next, and Satlyt, judged by a panel including Alexa von Tobel of Inspired Capital and Stacy Brown-Philpot of Cherryrock Capital.

One more data point for scale. On October 16, six US startups raised a combined $2.167 billion, and a single company, Ramp, accounted for roughly 85% of it. Ramp is a fintech extending into AI-related spending and automation. That concentration matters, and it leads directly to the first pattern.
| Company | Business | Amount raised | Round details | Key backers |
|---|---|---|---|---|
| Manus | General-purpose AI agents | More than $500 million | First round since the reversed Meta acquisition; round type not disclosed | Boyu Capital, IDG Capital; follow-on from Tencent, HSG, ZhenFund |
| Oratomic | Neutral-atom quantum hardware | $475 million | Series B at roughly $5.4 billion valuation; $775 million total raised since the March 2026 launch | ARCH Venture Partners, Spark Capital, Khosla Ventures, Index Ventures, General Catalyst, Bezos Expeditions |
| SignSplit | Paying humans for AI data | $400 million seed commitment | Emerged from stealth at a $1 billion valuation | W Group |
| Intero Biosystems | Lab-grown intestinal organoids (GastroScreen) | Battlefield Cup and $100,000 | Won TechCrunch Disrupt 2026, held October 13 to 15 in San Francisco | Not disclosed |
| Ramp | Fintech extending into AI spending and automation | Roughly 85% of a $2.167 billion day | Single biggest check of the week; six US startups raised that day | Not disclosed |
Why is AI funding moving into the supply chain?
Look at the smaller October 16 rounds and a pattern jumps out. Mueon is developing new ways to combine processing and memory. Machxin is commercializing automotive AI processors. Yuangui Materials supplies the specialized chemicals needed to manufacture advanced chips. North.cloud operates at the software and cost-management layer for AI computing.
Different companies, different constraints, one theme: none of them is training a frontier language model, and none of them needs to. Each one sells a pick or a shovel to the AI gold rush. Memory architectures, car chips, chip chemicals, cloud cost software: this is an industrial supply chain now, with the same structure as any mature industry. There are component makers, materials suppliers, and logistics layers, and investors are funding all of them.
The lesson for founders is encouraging. You do not need a billion-dollar training run to participate in the AI economy. You need to own one link in the chain that AI growth depends on. The October 5 funding news showed the same thing at a smaller scale: OneByZero's $20 million Series A, Pandektes' 13.5 million euro round, Fleuret AI's 4 million euro pre-seed, all backing applied AI layers (deployment, governance, domain workflows) rather than base models. The money is moving up the stack, from models to everything models need around them.

Why do the biggest checks follow commercial proof?
Ramp's share of that $2.167 billion day, about 85%, is the clearest signal in the week's data. Investors are willing to make very large commitments, but they are concentrating those commitments on a small number of businesses showing substantial revenue, real customer adoption, and room to expand into adjacent markets.
Read that carefully, because it is not "funding is back for everyone." The takeaway is narrower: the bar for a mega-round is now commercial scale, not a flashy demo. Ramp is not an AI model developer. It is a financial technology company with an existing business, extending into AI-related spending and automation. Investors paid up for the distribution and the revenue, and treated the AI angle as expansion fuel.
This is a healthy correction from the 2023 to 2024 era, when impressive demos could raise nine figures. The pendulum has swung toward businesses that can point to customers and cash flow. For an early-stage founder, the implication is direct: the fastest way to become fundable at scale is to become profitable-looking at small scale first. Revenue is the new demo.

Why does winning technology need operational control?
The third pattern is subtler but maybe the most useful for ordinary founders. Look at what the funded companies actually operate, not just what they build.
Abby Care organizes healthcare delivery through trained family caregivers. It is a technology company, but it also runs a care operation. Stand Insurance connects physical property analysis with insurance coverage. Sirona integrates diagnostic imaging with clinical workflows. Origin, which emerged from stealth on October 15 with $20 million from Accel, Zacua Ventures, Unilazer Ventures, Schema Ventures, Z21, ISAI, and Imad Ventures, is attempting to deliver completed construction tasks using autonomous robots. Not selling robots: delivering finished work.
The common thread is operational control. These companies do not just ship software and hope. They own the messy real-world process their software improves, which gives them two advantages: better data than any pure software competitor, and a business that works even if the technology advantage narrows. Investors have learned that a beautiful model with no operational grip is fragile. A good-enough model wrapped around a real operation is durable.
For a founder, this pattern is permission to get your hands dirty. The unglamorous operational work, the caregiving network, the construction crew scheduling, the property inspections, is not a distraction from the technology business. Increasingly, it is the moat.
What is the cautionary tale in this week's data?
Honest reporting requires the bad news too, and this week had plenty.
Character.AI, once among the most promising startups in generative AI, filed for bankruptcy and agreed to sell some of its assets to Disney for just $20 million. A company that raised at a multi-billion-dollar valuation ended with a $20 million asset sale. The cause, in plain terms: enormous compute costs and a business model that never caught up with them. Users loved the product. The unit economics did not work.
Meanwhile the International Monetary Fund warned that a sharp correction in AI stocks could threaten global financial stability, semiconductor shares tumbled across Asia on news from Chinese memory-chip maker CXMT, and Broadcom's chief executive compared some of today's AI investment activity to gambling. Anthropic added its own warning that future autonomous AI systems could spread across poorly secured household devices.
None of this means the boom is over. Oratomic tripled its valuation in the same week Character.AI went bankrupt. But it does mean the market is sorting, ruthlessly, between companies with economics that work and companies with stories that sounded good. The sorting is the point. Founders should read the bankruptcies as carefully as the mega-rounds, because the bankruptcies show exactly which mistakes are now fatal: scaling costs before revenue, depending on a single model advantage, and assuming the next round will always be there.
Startup funding trends 2026: what a small founder should take away
Five lessons, stated plainly.
1. Prove it small before you raise it big. The mega-rounds are going to companies with revenue, customers, and expansion room. If you want to raise serious money later, build serious traction now. The demo-to-term-sheet pipeline of 2023 is closed.
2. Own a link in the chain. You do not need to build the frontier model. Find one thing the AI economy depends on, data, a workflow, a material, a cost problem, and own it completely. The supply chain rounds this week prove investors will fund depth over breadth.
3. Expect geopolitics at the cap table. Manus's new backers are rooted in China after a reversed US acquisition. Cross-border AI deals are being redrawn in real time. If your startup touches AI infrastructure, assume your investor base will be shaped by forces larger than your pitch deck, and plan accordingly.
4. Wrap technology around operations. The most interesting funded companies run real-world operations, not just software. If you are choosing between a pure SaaS idea and one where you also operate the underlying service, the market is currently paying a premium for the latter.
5. Keep the unit economics honest. Character.AI is the cautionary tale of the week. Love from users does not pay for compute. However exciting your product, know your cost per user and your path to covering it, because the market has stopped grading on a curve.

One last thought. Most founders will never pitch a top-tier VC, and that is fine. These trends still matter to you, because they shape the tools you buy, the platforms you build on, and the customers you serve. When AI infrastructure gets cheaper and agent standards spread, as this week's x401 and x402 news suggests, the benefits flow downhill to everyone. If you are building a small business rather than a venture-scale startup, the freelance to full-time playbook is the more relevant next read. The funding weather affects every founder. You just need the right forecast for your altitude.
The bottom line
The second week of October 2026 showed one clear pattern. Investors wrote their biggest checks to companies with real revenue and real customers. Mega-rounds went to AI infrastructure, proven commercial scale, and startups pairing technology with operational control.
The decision rule for founders reading these headlines: ignore the round size and study the revenue. Manus survived a reversed acquisition with momentum intact. Oratomic sold a fault-tolerance roadmap as engineering rather than hope. Ramp took 85% of one day's capital by extending fintech into AI spend. Hype without revenue got punished the same week, as the Character.AI bankruptcy showed.
You will not raise $500 million this month. Almost nobody does. But the climate is legible: commercial proof is the currency, and the cautionary tales are as informative as the winners.
The same week that produced $500 million and $475 million rounds also produced a bankruptcy and an IMF warning about AI stock corrections, and that pairing is the real signal. Capital is concentrating in proven commercial scale while the cautionary tales pile up for companies that raised on promise alone. For a founder, the applied AI layers matter more than the mega-rounds: a $20 million Series A for deployment or data work is a market you can actually enter, while a half-billion round is a headline you can only watch.
Look below the mega-rounds for the pattern a small founder can actually use. The October 5 funding news showed the same thing at a smaller scale: OneByZero raised a 20 million dollar Series A, Pandektes raised a 13.5 million euro round, and Fleuret AI raised a 4 million euro pre-seed, all backing applied AI layers like deployment, governance, and domain workflows rather than base models. Sell the applied layer a customer can buy this quarter, not a foundation model that needs a 500 million dollar round to exist.
FAQ
How much did Manus raise in October 2026?
More than $500 million, announced October 8, 2026. It was the company's first round since Meta Platforms was forced to reverse its acquisition. Boyu Capital and IDG Capital led, with follow-on investment from Tencent, HSG, and ZhenFund. The round type was not disclosed.
Who won TechCrunch Disrupt 2026?
Intero Biosystems, a Denver startup spun out of the University of Michigan. Founders Charlie Childs and Madeline Eiken grow 1mm human intestinal organoids for drug and compound testing, and their GastroScreen product already sells to pharmaceutical, biotech, food, and chemical companies. They beat 19 other finalists for the $100,000 prize and the Disrupt Cup.
Where is venture capital going in late 2026?
Three places: AI infrastructure as an industrial supply chain (chips, memory, materials, cost software), concentrated mega-checks for companies with proven commercial scale, and startups that combine technology with real operational control. Pure model plays and hype without revenue are getting punished.
Is the AI funding boom over?
No, but it is sorting. The same week that produced $500 million and $475 million rounds also saw the Character.AI bankruptcy and an IMF warning about AI stock corrections. Money is still flowing at record levels for some companies. It is just flowing much more selectively, toward revenue, defensible technology, and honest economics.
What can a small founder learn from these mega-rounds?
Prove commercial traction early, own one useful link in the AI supply chain instead of building a base model, expect geopolitics to shape big AI deals, wrap your technology around a real operation, and keep unit economics honest from day one.
Want more practical guides like this?
Browse all 104 guides across 10 categories, no fluff, no paywall.
Browse all guides →Explore Business guides


